Construction and Characterization of a Replication-Defective Mutant of Equine Herpes Virus-1 (EHV-1) and Evaluation of Its Potential for Use as an Intranasal Live-Virus Vaccine for More Effective Prevention of EHV-1 Abortion in Mares